Detection of bacterial enteral pathogens
[Bakteriális enterális kórokozók kimutatása]
EPTIS Ringversuch Nr. 1258772 | Letze Änderung 2024-10-21 | URL: https://www.eptis.bam.de/pts1258772 https://www.eptis.bam.de/pts1258772
Name des Anbieters | ||||||||||||||||||||||
Name des Anbieters | QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. | |||||||||||||||||||||
Ansässig in | Hungary | |||||||||||||||||||||
Sprache(n) | English, Hungarian | |||||||||||||||||||||
Anmerkungen | Task: isolation and identification at species level of the enteric bacterial pathogen(s) responsible for the given enteric disease, based on professional guidelines, as well as determination of the antibiotic susceptibility. Interpretation of report towards the clinician, information about additional (e.g. epidemiological) tasks. If no pathogenic bacteria are found in the sample, report what further tests you would ask for. | |||||||||||||||||||||
Klassifizierung | ||||||||||||||||||||||
Produktgruppen |
Health care / medical devices
Human test material |
|||||||||||||||||||||
Prüfgebiete |
Medical analysis
|
|||||||||||||||||||||
Technische Einzelheiten | ||||||||||||||||||||||
|
||||||||||||||||||||||
Ringversuchsziele | ||||||||||||||||||||||
Zielgruppe des Ringversuchs | In vitro medical laboratories | |||||||||||||||||||||
Relevante Rechtsvorschriften oder Normen | ILAC_G8:09/2019 – Guidelines on Decision Rules and Statements of Conformity ISO 15189 – Medical laboratories – Requirements for quality and competence ISO/TS20658:2017 – Medical laboratories – Requirements for collection, transport, receipt and handling of samples VIM3 – Vocabulaire International de Métrologie WHO – Guidance on regulations for the Transport of Infectious Substances | |||||||||||||||||||||
Weitere Ziele | validation of testing methods | |||||||||||||||||||||
Teilnehmerzahl | ||||||||||||||||||||||
Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch NAH (National Accreditation Authority) auf der Grundlage von ISO/IEC 17043:2010 |
|||||||||||||||||||||
Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | ||||||||||||||||||||||
Kosten | ||||||||||||||||||||||
Teilnahmegebühr | on demand | |||||||||||||||||||||
Regelmässig durchgeführt | Ja (two times a year) | |||||||||||||||||||||
Der Ringversuch wird durchgeführt seit | 2019 | |||||||||||||||||||||
Kontaktdaten des Anbieters | ||||||||||||||||||||||
Anbieter | Kontaktperson | |||||||||||||||||||||
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
Feketesas u. 19-21. I/7 6720 Szeged Hungary Telefon: +36 30 462 5864 Fax: Web: http://www.qualicont.com/qc/index_en.html http://www.qualicont.com/qc/index_en.html |
Ms. Eszter Mezey
Telefon: +36 30 462 5864 Fax: E-Mail: mail@qualicont.com mail@qualicont.com |